MBX Biosciences, Inc. Common Stock
Veridion Score
Composite trend over time
Why is MBX moving today?
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include canvuparatide (MBX 2109), imapextide (MBX 1416), and MBX 4291.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for MBX.
MBX insider activity
MBX Biosciences, Inc. Common Stock
No multi-insider buying cluster in the last 90 days
Net buying: $12.2M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | 2026-05-08 | Azoulay Salomon | Insider | sell | $38.30 | 15,003 | 14,769 | $575K | SEC Form 4 |
| 2026-05-11 | 2026-05-08 | Azoulay Salomon | Insider | buy | $16.00 | 15,003 | 29,772 | $240K | SEC Form 4 |
| 2026-05-11 | 2026-05-08 | Azoulay Salomon | Insider | sell | $38.38 | 55,000 | 14,769 | $2.1M | SEC Form 4 |
| 2026-05-11 | 2026-05-08 | Azoulay Salomon | Insider | buy | $10.46 | 55,000 | 69,769 | $575K | SEC Form 4 |
| 2026-05-08 | 2026-05-06 | Azoulay Salomon | Insider | sell | $29.54 | 231 | 14,769 | $7K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 7 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moMBX contract awards, year to date.
Public federal awards linked to this ticker.
MBX lobbying filings, year to date.
Registered lobbying filings matched to MBX Biosciences, Inc. Common Stock.